Protective Cancer Vaccine Using Genetically Modified Hematopoietic Stem Cells
Hematopoietic stem cells (HSCs) yield both the myeloid and lymphoid lineages of blood cells and can be reprogrammed into tumor antigen (Ag)-specific CD8+ cytotoxic T lymphocytes (CTLs) to prevent tumor growth. However, the optimal approach for differentiating tumor Ag-specific CTLs from HSCs, such a...
| Main Authors: | , , , , , , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
MDPI AG
2018-07-01
|
| 叢編: | Vaccines |
| 主題: | |
| 在線閱讀: | http://www.mdpi.com/2076-393X/6/3/40 |